KKR to acquire a stake in health tech firm Cotiviti

Coherus Oncology

14/02/2024 15:16

Feb 14 (Reuters) - Private equity firm KKR & Co  KKR.N 
has agreed to acquire a stake in Cotiviti from private-equity
manager Veritas Capital, the healthcare technology firm said on
Wednesday.
    KKR was a leading contender to buy a 50% stake in Cotiviti
and a transaction would value it between $10 billion and $11
billion, sources familiar with the matter had told Reuters
earlier on Wednesday.

 (Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi
Majumdar)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))